Search

Author/Creator Jimenez, Teri

1. FRI0195 EFFICACY AND SAFETY OF DAPIROLIZUMAB PEGOL (DZP) IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A RANDOMISED, PLACEBO (PBO)-CONTROLLED STUDY. (June 2019)

Authors:
Furie, Richard; Bruce, Ian N.; Dörner, Thomas; Leon, Manuel Gustavo; Leszczynski, Piotr; Urowitz, Murray B.; Haier, Birgit; Jimenez, Teri; Barbey, Catherine; Liu, Jiajun; Stach, Christian
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
775
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus. (6th May 2021)

Authors:
Furie, Richard A; Bruce, Ian N; Dörner, Thomas; Leon, Manuel Gustavo; Leszczyński, Piotr; Urowitz, Murray; Haier, Birgit; Jimenez, Teri; Brittain, Claire; Liu, Jiajun; Barbey, Catherine; Stach, Christian
Journal:
Rheumatology
Issue:
Volume 60:Number 11(2021)
Page Start:
5397
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗